Clinical Trials

Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.

Title Phase Last Update

Actinium Therapy for Late-stage Aggressive Sarcomas (ATLAS)

Phase 1

Last update: July 15

Phase 1 July 15

Testing Lutetium Lu-177 Dotatate in Patients with Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Phase 2

Last update: July 15

Phase 2 July 15

The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments with a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer

Phase 2

Last update: July 15

Phase 2 July 15

Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Phase 1

Last update: July 15

Phase 1 July 15

Safety and Preliminary Efficacy of [Lu-177]Lu-RTX-2358 Combined with Immune Checkpoint Inhibitors in Patients with FAP-positive Metastatic Non-Small Cell Lung Cancer

Early Phase 1

Last update: July 14

Early Phase 1 July 14

Dosimetry of Tc-99m-Tilmanocept

Phase 1

Last update: July 14

Phase 1 July 14

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu-177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Phase 2

Last update: July 14

Phase 2 July 14

Optimizing Y90 Therapy for Radiation Lobectomy

N/A

Last update: July 14

N/A July 14

MANDARIN (S6371)

Phase 3

Last update: July 14

Phase 3 July 14

Real-world Experience with Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

N/A

Last update: July 13

N/A July 13